Business Description
LifeMD Inc
NAICS : 541519
SIC : 8099
ISIN : US21255M1099
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.72 | |||||
Equity-to-Asset | -0.07 | |||||
Debt-to-Equity | -4.95 | |||||
Debt-to-EBITDA | -1.92 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -0.55 | |||||
Beneish M-Score | -5.05 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.9 | |||||
3-Year EBITDA Growth Rate | 61.3 | |||||
3-Year EPS without NRI Growth Rate | 46 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 57.77 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.36 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 96.6 | |||||
9-Day RSI | 89.47 | |||||
14-Day RSI | 81.48 | |||||
6-1 Month Momentum % | -53 | |||||
12-1 Month Momentum % | -36.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 54.24 | |||||
Days Sales Outstanding | 9.98 | |||||
Days Payable | 213.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.9 | |||||
Shareholder Yield % | -3.44 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.92 | |||||
Operating Margin % | -10.78 | |||||
Net Margin % | -13.18 | |||||
FCF Margin % | 3.7 | |||||
ROA % | -45.21 | |||||
ROIC % | -61.3 | |||||
3-Year ROIIC % | 168.16 | |||||
ROC (Joel Greenblatt) % | -985.4 | |||||
ROCE % | -145.89 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 24.3 | |||||
PS Ratio | 1.51 | |||||
Price-to-Free-Cash-Flow | 42.28 | |||||
Price-to-Operating-Cash-Flow | 16.42 | |||||
EV-to-EBIT | -15.55 | |||||
EV-to-EBITDA | -27.12 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-Forward-Revenue | 1.1 | |||||
EV-to-FCF | 44.61 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | -6.43 | |||||
FCF Yield % | 2.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LFMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
LifeMD Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 178.28 | ||
EPS (TTM) ($) | -0.7 | ||
Beta | 2.01 | ||
Volatility % | 87.49 | ||
14-Day RSI | 81.48 | ||
14-Day ATR ($) | 0.450609 | ||
20-Day SMA ($) | 4.81325 | ||
12-1 Month Momentum % | -36.34 | ||
52-Week Range ($) | 3.99 - 12.88 | ||
Shares Outstanding (Mil) | 43.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
LifeMD Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
LifeMD Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
LifeMD Inc Frequently Asked Questions
What is LifeMD Inc(LFMD)'s stock price today?
When is next earnings date of LifeMD Inc(LFMD)?
Does LifeMD Inc(LFMD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |